A Korean clinical study is drawing attention, showing that new dopamine cells made by cloning embryonic stem cells can replace dead dopamine cells in the brain to treat Parkinson's disease.
The study results of the embryonic stem cell-derived Parkinson's disease treatment, which came 20 years after the “Hwang Woo-suk scandal,” show excellent safety and efficacy in a one-year clinical study, with experts saying that the incurable disease will likely be conquered soon
Transplanted brain neurons appear to remain healthy for up to 14 years
Adipose fat derive stem cell treatment for Parkinson's
Approved Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson's Disease Patients Worldwide in Japan
Stem cell treatment for Parkinson's Disease.
One-time treatment generates new neurons, eliminates Parkinson's disease in mice
